AuDStandard-ESCO Partnership to Boost Members’ Patient Loyalty, Retention
AuDStandard (www.audstandard.com) has partnered with ESCO (www.earserv.com), a leading comprehensive insurance provider for hearing instruments, to develop programs that promote coverage of lost and damaged hearing aids to AuDStandard members in an effort to help them improve business and increase patient loyalty and retention.
“We're very pleased to partner with ESCO and offer our members a trusted insurance solution that they can make available to patients,” said Tucker Worster, the CEO of AuDStandard. “Their loss, damage, and repair coverage options provide an affordable way for hearing health care practitioners to offer peace of mind to patients for the life of their hearing instruments.”
“ESCO is excited to partner with AuDStandard,” said Jim Guthier, the president of ESCO. “This relationship will bring with it a number of beneficial tools that AuDStandard members can use to improve their business. Our comprehensive coverage options, unsurpassed customer service, low premiums and payment plans, and efficient claims processing give hearing health care practitioners an attractive insurance option to offer patients and allows them to focus what they do best providing quality care.”
Signia Introduces New Hearing Aids in Marketing Campaign
Signia (https://www.signiausa.com/) has partnered with Mediaplanet to introduce Styletto, a new hearing aid designed to attract patients who have rejected wearing hearing aids in the past, in the marketing firm's Vision and Hearing campaign for Healthy Aging Month. Styletto features a sleeker and more distinctive look than traditional hearing aids, and is equipped with a slim, portable charging case that can provide up to four days of power to wearers with an active lifestyle such as vacationers and business owners. The new Signia hearing aid also includes all the benefits of the Signia Nx platform providing a natural sound like Own Voice Processing and ultra HD e2e wireless communication between hearing aids. It also comes with the Twin Phone feature, which allows wearers to hold a phone to one ear and hear the voice of the caller on the other end in both ears during phone conversations.
New Hearing Protection for Children from Puro Sound Labs
The new sound-isolating earmuffs PuroCalm from Puro Sound Labs (https://purosound.com/) protect children from loud and harmful noise and provide 27 dB of safe, comfortable, broad-spectrum noise reduction. PuroCalm creates a safe hearing level for children at concerts, sporting venues, zoos, aquariums, playgrounds, and other locations that might be too loud for extended hearing exposure. These earmuffs can also be used to avoid distraction while studying or sleeping on planes or to find relief from sensory overload in entertainment venues. Sized for those between 3 and 16 years old, PuroCalm features two soft and lightweight ear pads that are cushioned with foam and are rotatable and foldable. Puro Sound has partnered with KultureCity to donate a pair of PuroCalm to the nonprofit's Sensory Inclusive program for every pair of PuroCalm purchased.
Study Finds Sensorion Drug Effective against Hearing Loss
SENS-401, a therapy developed by Sensorion (http://www.sensorion-pharma.com/en/), has been shown to have otoprotective and hearing loss recovery potential in a new study (Otol Neurotol. 2018 Dec 17. doi: 10.1097/MAO.0000000000002088. [Epub ahead of print]). The Sensorion pre-clinical trial team evaluated the efficacy of SENS-401 at different doses and treatment windows in male rats with severe acoustic trauma-induced hearing loss using auditory brainstem response (ABR), distortion product otoacoustic emissions (DPOAE) measures, and outer hair cell (OHC) counting, and compared the results against those of placebo after 28 days. They found significant improvements in ABR threshold shifts and recovery, and DPOAE amplitude loss occurred with up to a 96-hour delay in initiating twice daily oral SENS-401 and in DPOAE amplitude recovery with up to 72 hours of delay. Significantly more surviving OHCs were present after SENS-401 treatment compared with placebo after a 24-to-96-hour delay post-trauma, with up to more than five times more cells in the basal cochlea turn. In vivo data support the otoprotective potential of SENS-401 with both immediate and delayed treatment initiation and has potential broader application to the general patient population with sudden sensorineural hearing loss.
Wireless Headphones Predicted to Incorporate Hearable Tech by 2022
More than 271 million audio-focused multimedia hearables will be in use by 2022, representing over 50 percent of all wireless headphone use, according to a new report by Juniper Research. The report, titled “Future Hearables: Strategies, Opportunities & Forecasts 2018-2023,” estimated that 417 million hearables will be in use by 2022, which include fitness-focused devices, hearing augmentation, and purely audio-focused devices. The research also predicted that over 75 percent of hearables in use will incorporate voice assistants by 2022 as mid-range and budget manufacturers leverage voice assistants to enhance their devices, and that assistive hearables will generate over $40 billion annually by 2022 as hearing aids integrate mobile technologies and maintain medical industry prices.